Does TRT 'stop working'? What's actually behind hormone plateau myths

What did @stevenfnp83 actually say?

The claim is that testosterone replacement therapy produces a dramatic early improvement, what he calls "the honeymoon," followed by a crash around 60 to 90 days in. His explanation: testosterone "doesn't fix a broken system, it amplifies it." If your sleep is off, your metabolism is sluggish, and your stress is high, TRT will just run that broken system faster. The fix, he argues, is to repair the foundation first, then use testosterone "like a tool and not a crutch."

This is a coherent argument, and it's one you'll hear from experienced hormone clinicians. But it blends real physiology with some oversimplifications worth pulling apart before you take it as gospel.

Does the science back this up?

Partly, yes. The early symptomatic response to TRT is well-documented, and so is the reality that lifestyle factors can blunt its effects. The specific 60-to-90-day crash framing is more clinical folklore than established pharmacology.

Testosterone cypionate and enanthate, the two most common injectable forms used in TRT, reach steady-state serum levels within roughly four to six weeks of consistent dosing. After that, levels aren't declining, which means a symptom return isn't explained by the drug wearing off. What researchers have found is more nuanced. A 2016 study by Hackett et al. in the Journal of Sexual Medicine showed that men with poorly controlled sleep apnea, metabolic syndrome, or high cortisol had significantly attenuated responses to testosterone therapy compared to men without those conditions. Sleep deprivation alone suppresses Leydig cell function and blunts androgen receptor sensitivity, which means even exogenous testosterone has less to work with in a sleep-deprived patient (Leproult and Van Cauter, 2011, JAMA). So the underlying mechanism he's pointing at is real, even if the timeline he gives is somewhat arbitrary.

What did they get wrong (or right)?

He got the core mechanism right. He got the timeline wrong, and he didn't explain why the crash actually happens, which matters if you're a patient trying to understand your own body.

The "honeymoon" effect is real, but it's not purely pharmacological. Some of the early euphoria from starting TRT is a placebo-adjacent response, the relief of finally doing something after months of feeling terrible. Research by Bhasin et al. (2010, New England Journal of Medicine) confirmed that symptomatic improvement in hypogonadal men is real and measurable, but also noted that baseline metabolic health is a strong predictor of sustained response.

Where he oversimplifies: he implies that lifestyle is the primary reason TRT stops "working." In reality, there are other legitimate explanations for symptom recurrence, including suboptimal dosing, elevated estradiol from aromatization, rising hematocrit affecting circulation, or secondary SHBG changes that reduce free testosterone. None of those are mentioned, and they're not small issues. A patient who hears this video might spend months overhauling their sleep when the actual problem is an estradiol level that needs managing.

• Right: Sleep, stress, and metabolic health affect TRT outcomes.
• Right: TRT is not a substitute for addressing root-cause health issues.
• Wrong: The 60-to-90-day crash is not a documented pharmacological event with a single cause.
• Missing: Estradiol, SHBG, hematocrit, and dosing adequacy are also common culprits.

What should you actually know?

If you're on TRT and feeling worse after an initial improvement, the answer is labs, not just lifestyle changes. Both things can be true at once: your sleep habits matter, and your estradiol might also be elevated. These are not mutually exclusive problems.

The clinical evidence supports the general principle that TRT works better in men who also address sleep apnea, reduce visceral fat, and manage chronic stress. A 2021 meta-analysis by Corona et al. in Andrology found that metabolic syndrome significantly reduced the magnitude of testosterone's effect on sexual function and energy outcomes. That's meaningful data supporting his broader point.

But "fix your foundation first" as a blanket rule can delay legitimate treatment for men with confirmed hypogonadism. Clinical guidelines from the Endocrine Society (Bhasin et al., 2018) recommend initiating TRT in symptomatic men with consistently low total testosterone, while simultaneously addressing comorbidities. The sequence isn't always lifestyle first, drugs second. It's often both, managed together, with regular lab monitoring driving decisions.

If a provider is not checking your labs every three to six months in the first year of TRT, that's the real problem worth addressing.